🇺🇸 FDA
Patent

US 10881714

Methods and compositions for oral administration of proteins

granted A61KA61K35/60A61K38/2278

Quick answer

US patent 10881714 (Methods and compositions for oral administration of proteins) held by Oramed Ltd. expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Oramed Ltd.
Grant date
Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K35/60, A61K38/2278, A61K38/28, A61K38/56